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Inflammatory bowel disease (IBD) is an impor-
tant risk factor that favors the development and 
progression of colitis-associated cancer (CAC; 
Eaden et al., 2001; Terzić et al., 2010; Rubin 
et al., 2013). Even in the absence of overt in-
flammatory disease in colorectal cancer (CRC), 
loss of barrier function in the tumor epithelium 
enables translocation of microbial products into 
tumor tissue. This triggers the activation of 
lamina propria immunocytes and colonic epi-
thelial cells via pattern-recognition receptors 
(PRRs) to produce cytokines and chemokines. 
Those factors then promote tumor growth and 
mediate recruitment of further immune cells 
(Grivennikov et al., 2012; Mueller, 2012). Al-
ternatively, epithelial innate immune compo-
nents could be subverted during tumorigenesis 
and influence tumor growth independently. 
Although cytokine/chemokine-mediated mod-
ulation of tumor growth has been described, 
the role of epithelial-intrinsic, innate immune 
components still remains elusive.
Several Nod-like receptors (NLRs) have 
previously been implicated in colon inflam-
mation and tumorigenesis, mostly in protective 
roles (Allen et al., 2010; Hu et al., 2010; Chen 
et al., 2011; Elinav et al., 2011; Zaki et al., 
2011; Carvalho et al., 2012). In some cases, this 
has been attributed to reduced inflammasome-
mediated release of IL-18, which is protective 
for the colonic epithelium (Allen et al., 2010; 
Dupaul-Chicoine et al., 2010). In other cases, 
noninflammasome-mediated factors were 
found to protect mice against CAC develop-
ment. For example, NLRP12 was protective 
against colonic inflammation and tumorigene-
sis by dampening NF-B and ERK activation 
in macrophages (Zaki et al., 2011). However, 
several discrepancies also exist, as illustrated by 
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NLR family apoptosis inhibitory proteins (NAIPs) belong to both the Nod-like receptor 
(NLR) and the inhibitor of apoptosis (IAP) families. NAIPs are known to form an inflamma-
some with NLRC4, but other in vivo functions remain unexplored. Using mice deficient for 
all NAIP paralogs (Naip1-6/), we show that NAIPs are key regulators of colorectal tumor-
igenesis. Naip1-6/ mice developed increased colorectal tumors, in an epithelial-intrinsic 
manner, in a model of colitis-associated cancer. Increased tumorigenesis, however, was not 
driven by an exacerbated inflammatory response. Instead, Naip1-6/ mice were protected 
from severe colitis and displayed increased antiapoptotic and proliferation-related gene 
expression. Naip1-6/ mice also displayed increased tumorigenesis in an inflammation-
independent model of colorectal cancer. Moreover, Naip1-6/ mice, but not Nlrc4-null 
mice, displayed hyper-activation of STAT3 and failed to activate p53 18 h after carcinogen 
exposure. This suggests that NAIPs protect against tumor initiation in the colon by promot-
ing the removal of carcinogen-elicited epithelium, likely in a NLRC4 inflammasome-
independent manner. Collectively, we demonstrate a novel epithelial-intrinsic function of 
NAIPs in protecting the colonic epithelium against tumorigenesis.
© 2015 Allam et al. This article is distributed under the terms of an Attribution– 
Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial– 
Share Alike 3.0 Unported license, as described at http://creativecommons.org/ 
licenses/by-nc-sa/3.0/).
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domains appeared to be necessary for NLRC4 inflamma-
some formation and activation of caspase-1 (Kofoed and 
Vance, 2011).
A mouse model lacking all Naip paralogs has not been 
available, preventing definitive analysis of NAIPs physiological 
function. In this study, we describe the first complete Naip1-6 
knockout mice and demonstrate a crucial role for NAIPs in 
preventing colonic tumor initiation and progression.
RESULTS
Naip1-6 knockout mice develop normally
C57BL/6 mice have four functional copies of Naip (1, 2, 5, 
and 6) and two noncoding (nc) copies ( and 3; Fig. 1 A). 
Using a two-step targeting strategy, we generated C57BL/6 
mice containing loxP sites flanking the Naip locus (Naip1-6fl/fl; 
Fig. 1, A–D). These mice were crossed with CMV-cre deleter 
mice (10 generations on C57BL/6 background) to generate full-
body knockout of the Naip locus (Naip1-6/). Naip1-6/, 
and Naip1-6fl/fl mice bred as concurrent nonlittermate homo-
zygous lines were used in most experiments, except where 
littermates are indicated. Naip1-6/ mice were indistinguish-
able from their WT Naip1-6fl/fl counterparts when housed 
under specific pathogen–free conditions for up to one year. 
FACS analysis of immune cell subsets in the spleen and BM 
showed normal T cell, B cell, monocyte, and granulocyte 
populations (Fig. 1 E).
Naips are highly expressed in the colon  
and innate immune cells
We observed the highest expression of Naips in the large in-
testine, with increasing levels from the cecum to the distal 
colon (Fig. 1 F). Naips are also expressed in innate immune 
cells such as macrophages, dendritic cells, and neutrophils 
(Fig. 1 F; and BioGPS gene annotation portal). Similarly, 
high expression of human NAIP was reported in the colonic 
epithelium and in innate immune cells (Diez et al., 2000; see 
also BioGPS and the Human Protein Atlas). Expression of 
Naips in the colon would be congruent with their role in 
detecting enteric pathogens such as Salmonella (Kofoed and 
Vance, 2011; Zhao et al., 2011; Sellin et al., 2014); but it also 
raises the question of whether NAIPs play any other physio-
logical role in this organ.
TLR and inflammasome responses in Naip1-6/ mice
Naip1-6/ BM-derived macrophages (BMDMs) responded 
normally to a range of Toll-like receptor (TLR) ligands with 
regard to production of the cytokines IL-6 and IL-10 (Fig. 2 A). 
However, consistent with NAIP’s role in NLRC4 inflamma-
some activation (Kofoed and Vance, 2011; Zhao et al., 2011; 
Yang et al., 2013), upon infection of Naip1-6/ BMDMs 
with Salmonella typhimurium (S.Tm), IL-1 production and 
pyroptosis were severely attenuated (Fig. 2, B and C). Priming 
with LPS resulted in normal induction of pro–IL-1, further 
confirming intact TLR responses in Naip1-6/ BMDMs 
(Fig. 2 C). NLRP3 inflammasome activators (Fig. 2 C), and 
AIM2 inflammasome activator poly(dA:dT; not depicted), 
Caspase-1–deficient mice, which display increased colon tu-
morigenesis. In one study, this was dependent on NLRC4 
and was epithelial intrinsic rather than inflammation medi-
ated (Hu et al., 2010), whereas, in another study, increased 
tumorigenesis involved NLRP3 and was inflammation and 
hematopoietic cell–dependent (Allen et al., 2010). Such dis-
crepancies are suggested to arise from differences in micro-
biota between facilities or use of WT mice from external 
sources (Ubeda et al., 2012), but could also arise from oppos-
ing functions of inflammasome components in different tis-
sues, which has been demonstrated in a skin tumorigenesis 
model (Drexler et al., 2012).
The physiological function of the NLR protein NAIP 
(NLR family apoptosis inhibitory protein, previously known 
as neuronal apoptosis inhibitory protein) is not fully charac-
terized, mainly because mice have several possibly redundant 
Naip paralogs (e.g., 4 functional and 2 noncoding Naip genes 
in the C57BL/6 genome; Yaraghi et al., 1998; Endrizzi et al., 
2000; Growney and Dietrich, 2000). Humans also have sev-
eral NAIP genes, only one of which is full length (Schmutz 
et al., 2004; Romanish et al., 2009). NAIPs are intracellular, 
cytosolic proteins with a tripartite structure; three N-terminal 
baculovirus inhibitor of apoptosis (IAP) protein repeat 
(BIR) domains, a central NACHT domain and C-terminal 
leucine rich-repeat (LRR) domains. The latter two domains 
group NAIPs to the NLR family of proteins. Indeed, NAIPs 
are best characterized for their inflammasome function. 
Mouse and human NAIPs are involved in the detection of 
intracellular pathogens, such as Salmonella, and activation of the 
NLRC4 inflammasome, inducing pyroptosis and caspase-1–
mediated cleavage of IL-1 and IL-18 (Kofoed and Vance, 
2011; Zhao et al., 2011; Rayamajhi et al., 2013; Yang et al., 
2013). In mice, NAIP paralogs provide specificity to different 
bacterial components (Kofoed and Vance, 2011; Zhao et al., 
2011). In vivo, the NAIP5-NLRC4 inflammasome was 
required for sepsis-induced mortality by an Escherichia coli  
pathobiont or by systemic delivery of intracellular-targeted 
flagellin, although partial redundancy to other Naip paralogs 
was apparent (Ayres et al., 2012; von Moltke et al., 2012).
NAIPs also belong to the IAP family due to three 
N-terminal BIR domains; but whether they actually function 
as inhibitors of apoptosis is controversial. Some studies show 
direct binding and inhibition of caspase-3 and -9 (Maier et al., 
2002; Davoodi et al., 2004, 2010), but others do not (Roy 
et al., 1997). Also, NAIPs lack certain caspase-interaction 
residues within the BIR domains that would be necessary for 
direct inhibition of caspases, raising concern about whether 
NAIP can inhibit caspases in physiological settings (Scott 
et al., 2005; Eckelman and Salvesen, 2006; Eckelman et al., 
2006). Additionally, NAIPs mediate inflammasome-induced 
caspase-1 activation and induction of pyroptosis via NLRC4, 
which is contrary to the suggested inhibitor of apoptosis 
function (Kofoed and Vance, 2012). BIR domains, however, 
can mediate a broad range of protein–protein interactions 
and therefore could be implicated in diverse cellular func-
tions in addition to inhibition of caspases. In NAIPs, the BIR 
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Figure 1. Generation of Naip1-6 knockout mice and Naip tissue expression. Naip1-6 knockout mice were generated at Ozgene Pty. Ltd. using 
C57BL/6 material (DNA, blastocysts and ES cells). (A) Schematic of the targeting strategy (Naip locus schematic adapted from; Endrizzi et al., 2000). First, 
the region between the Smn and Naip2 genes was targeted with a vector containing neomycin selection flanked by loxP sites (HA, homology arms). Tar-
geted ES cells were selected using neomycin (Neo) and germline transmission of the mutation was achieved. (B) Southern blot demonstrating the pres-
ence of WT or floxed allele (A2 to A5 represent different mice). ES cells were then isolated from the resulting heterozygous mice and used for the second 
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cytokines within tumors of both genotypes (Fig. 3 F), which 
would be congruent with decreased barrier function within 
tumor epithelium (Grivennikov et al., 2012). Expression of 
IL-6, IL-11, IL-12, and Tnf were all significantly higher in 
Naip1-6/ tumors compared with Naip1-6fl/fl (Fig. 3 F). 
Because IL-6 and IL-11 can activate STAT3 (Bollrath 
et al., 2009; Putoczki et al., 2013), increased pSTAT3 
observed in Naip1-6/ tumors might be related to the 
observed up-regulation of those cytokines. Also consistent 
with STAT3 activation, downstream targets Mmp9 and 
Timp1, which can act to enhance tumor growth or invasion 
(Kim et al., 2012; Shuman Moss et al., 2012), as well as 
Stat3 itself, were elevated (Fig. 3 F). In contrast, transcripts 
for each of the Naips were significantly down-regulated in 
tumor tissue, compared with surrounding nontumoral tis-
sue of WT mice (Fig. 3 G). This suggests that reduced ex-
pression of all Naip paralogs could be associated with tumor 
progression, and therefore that they may all play a role in 
this phenotype.
Analysis of inflammasome activation in tumoral and non-
tumoral tissues of Naip1-6fl/fl and Naip1-6/ mice revealed 
reduced mature IL-18, but increased IL-1 levels in tumors 
of both genotypes (Fig. 3 H). Because this was performed on 
whole-tissue homogenates, it is not possible to distinguish 
between colonic epithelium and hematopoietic-derived 
cytokine, which may account for the different regulation of 
IL-18 and IL-1. Cleaved caspase-1 was also similarly detected 
at a low level, in both genotypes, with slight increase in tumor 
tissue (Fig. 3 H). These results make it unlikely that tumor 
progression in Naip1-6/ would be caused by differences in 
inflammasome-derived cytokines.
Collectively, this data shows increased tumor develop-
ment in Naip1-6/ mice compared with Naip1-6fl/fl. Both 
genotypes showed induction of an inflammatory milieu in 
developed tumors, but this was more marked in Naip1-6/ 
mice. In addition, Naip1-6/ tumors had increased levels 
of proliferation markers (ki67) and STAT3 activation, which 
might, at least in part, account for the increased tumor size. 
No major differences in IL-18 and IL-1 were observed be-
tween genotypes, indicating normal activation of canonical 
inflammasomes in Naip1-6/ mice. In addition, the down-
regulation of Naips in WT tumors further suggests a role for 
Naips in tumor suppression.
induced similar levels of caspase-1 activation and IL-1 pro-
duction in both Naip1-6fl/fl and Naip1-6/ BMDMs, indi-
cating that other inflammasomes are intact in the Naip1-6/ 
mouse. We observed residual activation of Caspase-1 and 
production of IL-1 in Naip1-6/ BMDMs stimulated with 
high titers of S.Tm (Fig. 2, B and C), in line with previous 
observations of NLRC4-independent, NLRP3-mediated 
detection of S.Tm (Broz et al., 2010).
Naip1-6/ mice have increased colon tumorigenesis
NAIPs have been suggested to act as tumor promoters be-
cause they are IAP family members. However, whether they 
act as IAPs is controversial. Additionally, NAIPs belong to the 
NLR family, and several NLRs are protective in colonic in-
flammation and tumorigenesis, through a variety of mecha-
nisms (Allen et al., 2010; Hu et al., 2010; Chen et al., 2011; 
Elinav et al., 2011; Zaki et al., 2011; Carvalho et al., 2012). 
Naip1-6fl/fl and Naip1-6/ mice (nonlittermates) were chal-
lenged in a CAC model with administration of the carcin-
ogen azoxymethane (AOM; 10 mg/kg) followed by three 
cycles of dextran sulfate sodium (DSS; 2.5% wt/vol) to 
induce colitis and accelerate tumorigenesis. Colonic endos-
copy assessment after the last dose of DSS revealed greater 
tumor burden in Naip1-6/ mice compared with Naip1-6fl/fl  
(Fig. 3 A). Autopsy confirmed increased tumor burden, and 
also increased tumor size, in Naip1-6/ mice (Fig. 3, B–D). 
Histological analysis of tumors demonstrated development of 
tubular adenomas with high-grade dysplasia in Naip1-6/ 
mice, whereas Naip1-6fl/fl mice mostly had low-grade dyspla-
sia, with only a few cases of high-grade dysplasia (Fig. 3 E). 
Naip1-6/ tumors showed increased staining for ki67 com-
pared with Naip1-6fl/fl tumors (Fig. 3 E), indicating increased 
proliferation, which is consistent with the increased tumor 
size. In accordance with this, STAT3 was highly phosphory-
lated and located in the nucleus of Naip1-6/ tumor epithe-
lium (as well as in infiltrating leukocytes; Fig. 3 E). However, 
tumors in Naip1-6fl/fl showed very little pSTAT3 staining in 
epithelial cells (but did have pSTAT3-expressing infiltrating 
leukocytes; Fig. 3 E). STAT3 activation is an important stimulus 
for tumor growth (Levy and Darnell, 2002; Bollrath et al., 
2009; Terzić et al., 2010).
Analysis of transcripts within tumor and in adjacent nontu-
moral tissue revealed an up-regulation of many proinflammatory 
targeting of the 3 end of the Naip locus, between Naip1 and Gtf2h2. Successfully double-targeted ES cells were used to generate the double-floxed Naip 
mice (Naip1-6fl/fl). (C) Southern blot confirmation of double-targeted Naip allele (A25, mouse sample ID A25; neg, negative control; Neo, neomycin con-
trol; Hygro, hygromycin control). Naip1-6fl/fl mice were crossed with general deleter CMV-Cre recombinase mice to generate the full knockout mice 
(Naip1-6/). (D) PCR detection of floxed or KO alleles. (E) Spleen from Naip1-6fl/fl and Naip1-6/ mice were stained for B220, CD23, CD3, CD4, CD8 and 
CD25 and analyzed by flow cytometry. BM cells were stained for Ly6G&C, Ly6G, CD11b, B220, CD19, and IgM and analyzed by flow cytometry. Specific 
cell populations are indicated above each graph. n = 3 mice per group. Data are representative of two experiments. (F) Tissues were dissected from 
C57BL/6 mice, immune cell subsets were FACS-sorted from spleens, RNA was isolated from these samples, and qPCR analysis for Naips was performed 
using pan Naip1-6, as well as Naip1, Naip2, and Naip5-6–specific primers. Data were normalized to 18S rRNA expression. Data are representative of tis-
sues isolated from three individual mice at independent time points. Spleen subsets were obtained from pooled samples and are representative of two 
independent experiments.
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Inflammasome activation during DSS-induced colitis has 
previously been shown to be protective, particularly through 
the production of IL-18. IL-18 and IL-1 were induced at 
the protein level in colon lysates of both genotypes after DSS 
(Fig. 4 I). IL-22bp mRNA was shown to be negatively regu-
lated during DSS colitis in a time-dependent manner and also 
after biopsy-induced damage. In the biopsy model, this regu-
lation was absent in NLRP3 and NLRP6 inflammasome- 
deficient mice (Huber et al., 2012). We observed no change in 
IL-22BP in DSS exposed animals, with no difference be-
tween genotypes (Fig. 4 I). This is in contrast to Huber et al. 
(2012); however, the DSS dosing and timing, and line sus-
ceptibility, may affect the timing of IL-22BP protein and 
mRNA regulation. This data indicates that inflammasomes 
other than NAIP/NLRC4 are activated during acute colitis, 
but neither IL-18 and IL-1, nor IL-22 BP levels, play a role 
in the Naip1-6/ phenotype.
We then compared gene expression after AOM and DSS 
exposure in Naip1-6fl/fl and Naip1-6/ mice. Analysis of 
mRNA expression in colon homogenates revealed a reduc-
tion of IL-1, IL-6, IL-17, and Cxcl1 transcript levels in 
Naip1-6/ mice (Fig. 4 J), consistent with reduced disease 
severity. In contrast, antiapoptotic, proliferation, or survival-
related genes Bcl-2, Bcl-xL, Myc, Ras, Mdm2, Ccnd1 (Cyclin D1), 
Decreased colitis in Naip1-6/ mice
The inflammatory response to DSS-induced tissue damage 
is an important tumor promoter in the CAC model (Terzić 
et al., 2010). However, we observed reduced signs of colitis 
in Naip1-6/ mice during the AOM/DSS protocol, in-
cluding reduced weight loss and reduced colon shortening 
(Fig. 4 A). To further assess the colitis phenotype, we ana-
lyzed mice after 7 d of oral DSS exposure (acute colitis). 
The severity of colitis in Naip1-6/ mice was reduced when 
compared with Naip1-6fl/fl mice, with reduced weight loss, 
disease activity index, and colon shortening (Fig. 4, B–D). 
There was also diminished myeloperoxidase activity, in-
dicative of reduced neutrophil accumulation in the colon 
(Fig. 4 E). Histological analysis also demonstrated reduced 
immune cell infiltrates and protection from mucosal dam-
age and loss of mucous-producing goblet cells in Naip1-6/ 
mice (Fig. 4, F and G). mRNA levels of all Naip paralogs 
were reduced in the distal colon after 7 d of DSS (Fig. 4 H), 
although expression was not altered in the proximal or 
mid colon (not depicted). Intriguingly, the distal colon is 
the site of greatest tumorigenesis in this model. This might 
suggest that Naips are down-regulated to enable epithelial 
repair, or might reflect loss of NAIP-expressing cells dur-
ing colon damage.
Figure 2. TLR and inflammasome activation in Naip1-6/ 
BMDMs. (A) Naip1-6fl/fl and Naip1-6/ BMDMs were stimu-
lated with a range of TLR ligands for 6 h. Supernatants were 
analyzed by ELISA for IL-6 and IL-10 production. Data are 
representative of two experiments. (B) BMDMs from  
Naip1-6fl/fl and Naip1-6/ mice were prestimulated with LPS 
(20 ng/ml), and then infected with Salmonella (S.Tm; SB300 
WT) at the indicated multiplicity of infection (MOI). Cell  
supernatants were collected after 2 h for analysis. IL-1 
production was measured by ELISA. Cell death was measured 
by lactate dehydrogenase (LDH) release and results were 
normalized to a positive control for cell death. Data  
are representative of greater than three experiments.  
(C) Naip1-6fl/fl and Naip1-6/ BMDMs were primed  
with LPS and stimulated with inflammasome activators; MSU 
(300 µg/ml), R837 (20 µg/ml), and S.Tm at the indicated MOI. 
Expression of pro-IL-1, IL-1, pro-caspase-1, and caspase-1 
was assessed by Western blot. (top) Cell extract (XT);  
(bottom) cell supernatant (SN). Data are representative  
of three independent experiments, conducted on BMDM  
obtained from one or two mice for each experiment.
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Figure 3. Increased colon tumorigenesis in Naip1-6/ mice AOM/DSS CAC model. Naip1-6fl/fl and Naip1-6/ (nonlittermates) mice were 
injected i.p. with AOM (10 mg/kg) on day 1 and on day 0 mice were treated DSS (2.5% wt/vol) in the drinking water for 7 d, followed by 14 d of 
normal drinking water. DSS treatment was repeated twice. Mice were sacrificed after last DSS exposure on day 56. (A) Representative endoscopic 
view at day 55 and colonoscopy score. (B) Macroscopic appearance of colons at autopsy (day 56) shows tumor development in distal colon,  
(C) tumor burden, and (D) tumor size, expressed as percent of tumors in the entire cohort observed in the indicated size range. (E) Immunohistology 
JEM Vol. 212, No. 3
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In this experiment, mice received DSS for only 5 d, explain-
ing why the impact on weight loss, colon shortening and 
tumor burden was less prominent than in other experiments. 
Naip1-6/LysM mice displayed a slight reduction of colitis in 
the early phase but no protection after 9 d, and colons exhib-
ited equivalent shortening compared with WT littermates 
(Fig. 5 F). A role for Naips in myeloid cells in the initial phase 
of colitis could reflect activation of myeloid cells (macro-
phages or neutrophils) after barrier disruption. Together, this 
data indicates that NAIP deficiency in the colonic epithe-
lium, and not in resident or infiltrating myeloid cells, drives 
the increased tumorigenesis.
Increased tumorigenesis in AOM-only model of CRC
Typically, decreased colonic inflammation is associated with 
decreased tumorigenesis. However, Naip1-6/ mice developed 
significantly more tumors than controls (Fig. 3, A–D), despite 
decreased inflammation (Fig. 4, A–G). This lack of correlation 
between tumorigenesis and inflammation led us to check 
whether Naip1-6 deficiency could also lead to increased tu-
morigenesis in an inflammation-independent setting. To test 
this, we used a model of AOM-induced CRC that is free of 
DSS or other inflammatory challenges (Schwitalla et al., 
2013). Mice were injected with AOM (10 mg/kg) once per 
week for 6 wk and were assessed for tumor burden after 24 wk. 
Naip1-6/ mice had increased tumor burden, assessed by 
colonoscopy and at autopsy, compared with those of Naip1-6fl/fl 
mice (Fig. 6, A and B). Naip1-6/ tumors also tended to be 
larger compared with Naip1-6fl/fl mice; however, both geno-
types had a similar percentage of tumors greater than 3 mm 
(Fig. 6 C). These data demonstrate that Naip deficiency can 
drive increased tumorigenesis in an inflammation-independent 
manner, and point toward a role in tumor initiation.
Altogether, this data suggests that the initiation of tumori-
genesis by AOM is sufficient for increased tumorigenesis in 
Naip1-6/ mice. Furthermore, in the setting of AOM/DSS 
CAC, the tissue-protective response observed in Naip1-6/ 
mice in response to DSS, in addition to the induction of an 
inflammatory milieu in developed tumors, could act to pro-
mote tumor growth.
The early response to AOM is altered in Naip1-6/ mice
AOM induces O-6 methylguanine adducts on DNA guanine, 
causing G-to-A base changes, which usually elicits a wave of 
p53-mediated apoptosis that can be detected early after AOM 
injection (Hu et al., 2002; Kerr et al., 2013; Schwitalla et al., 
2013). Failure to repair damaged DNA, or to eliminate AOM-
mutated cells, leads to increased tumor burden (Schwitalla et al., 
and IL-22 were all increased in Naip1-6/ mice (Fig. 4 J). 
This indicates that reduced colitis was not a result of failure to 
react to DSS-induced damage, but rather that tissue protec-
tive and regenerative responses were elicited.
Colitis was also assessed among littermates to rule out any 
effect of microbiota drift between the Naip1-6/ and Naip1-6fl/fl 
mice, which were bred as concurrent homozygous lines. In 
litters of Naip1-6fl/fl, Naip1-6fl/, and Naip1-6/, the Naip1-
6/ mice still displayed less severe colitis, with reduced weight 
loss and less reduction in colon length compared with Naip1-
6fl/fl and Naip1-6fl/1-6 (Fig. 4 K). Naip heterozygotes showed 
slightly less severe weight loss but a similar degree of colon 
shortening as Naip1-6fl/fl (Fig. 4 K). This demonstrates that 
the phenotype of Naip1-6/ mice is not a result of microbi-
ota drift between parental lines.
Altogether, this data suggests that Naip1-6/ mice are 
protected from severe DSS-induced epithelial damage be-
cause increased survival and proliferation maintains epithelial 
integrity. By keeping an intact epithelial barrier, the Naip1-6/ 
colon would be protected from the ensuing inflammation 
that follows epithelial barrier disruption. However, the pro-
survival and proliferative response could also act to promote 
tumor progression.
Increased tumorigenesis is epithelium intrinsic
Next, we wanted to determine which tissue was responsi-
ble for NAIP protection against tumorigenesis. Because 
NAIPs are highly expressed in the colon and in the innate 
immune myeloid cell compartment, we generated epithelial 
(Naip1-6/IEC) and myeloid (Naip1-6/LysM) cell–specific 
Naip KO mice by crossing Naip1-6fl/fl mice to Villin-cre or 
LysM-cre, respectively (both are on the C57BL/6 back-
ground), and performed the AOM/DSS CAC model. Loss of 
Naips via Villin-cre deletion almost completely removed Naip 
expression from the colon, indicating the high expression 
of Naips within colonic epithelial cells (Fig. 5 A). Naips 
knockout in LysM-cre-deleted mice was around 75% in BM 
Ly6GCD11b+ macrophages (Fig. 5 B). Deletion efficiency 
by LysM-cre has been shown to vary across the myeloid lin-
eage (Clausen et al., 1999).
Similar to the full Naip1-6/ mice, Naip1-6/IEC mice 
showed increased tumorigenesis compared with littermate 
Naip1-6fl/fl mice, with increased tumor burden and tumor 
size (Fig. 5 C). Naip1-6/LysM mice, however, showed the 
same tumor burden as littermate controls (Fig. 5 D). Colitis 
assessed during the AOM/DSS protocol showed a significant 
difference in Naip1-6/IEC mice with higher weight and less 
colon shortening compared with Naip1-6fl/fl mice (Fig. 5 E). 
staining for H&E showing representative tumor sections (bars, 500 µm) and ki67 and pSTAT3T705 (showing tumors of relatively similar development 
to enable comparison of proliferation; bars, 50 µm). Bar graphs on the right show quantification of ki67 and pSTAT3 expression. All tumors  
imaged were in the distal 1–2 cm of colon. (F) Relative expression levels of indicated mRNAs isolated from tumors T or the adjacent normal tissue N  
(normalized to 18S rRNA). (G) Same as F for the indicated Naips in Naip1-6fl/fl mice. (H) Western blot analysis for IL-18, Caspase-1, and IL-1 in 
normal and tumor tissue. Data are representative of two independent experiments with six to eight male mice per group. Data are shown as 
mean ± SEM. *, P < 0.05; **, P ≤ 0.01; ***, P ≤ 0.001; ****, P < 0.0001.
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Figure 4. Decreased colitis severity in Naip1-6/ mice. (A) Change in body weight was assessed at the indicated time points and the length of 
colons at autopsy of mice undergoing the AOM/DSS CAC model (as per Fig. 3). (B–I) Mice were treated with DSS (2.5% wt/vol) in the drinking water for  
7 d, and were sacrificed and tissues analyzed on day 7. n = 5 for each group. (B) The percent change in weight of Naip1-6fl/fl and Naip1-6/ mice at the 
indicated time points; n = 5 mice per group (n = 3 for untreated controls [Ctrl]). (C) Disease activity index on day 6 of the treatment. (D) Colon length. 
(E) Myeloperoxidase measurements of colon homogenates, expressed as optical density at 450 nm. (F) Histopathology scores performed blinded on H&E-
stained colon sections. (G) Representative sections of colons stained with H&E and periodic acid-Schiff stain (PAS). Bars, 100 µm. (H) Expression of Naips 
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of Bcl2, Myc and Ccnd1 (cyclin D1; Fig. 7, C and D), which is 
consistent with increased survival and proliferation. This sug-
gests that the increased tumor burden observed in Naip1-6/ 
mice results from an altered response to AOM.
The phenotype of Naip1-6/ mice, namely increased 
colon tumors in a context of lower inflammation, has been 
described before in gp130Y757F mice, which express hyper-
activated STAT3 (Bollrath et al., 2009). Similarly, IL-6/ mice 
display increased colitis severity but decreased tumorigenesis, 
largely due to defective STAT3 activation (Grivennikov et al., 
2009). Although STAT3 involvement in tumor progression 
is well established (Levy and Darnell, 2002; Bollrath et al., 
2009; Terzić et al., 2010), a role in tumor initiation is less 
studied. However, a few studies have demonstrated a role for 
STAT3 in initiation of a skin tumorigenesis model (Chan 
et al., 2004; Miyatsuka et al., 2006; Kim et al., 2009) and in 
2013). Because Naip1-6/ mice developed increased tumor 
burden in the AOM-only model of CRC, we assessed the role 
of NAIPs in tumor initiation. Mice were injected with AOM 
(10 mg/kg) and the colons were analyzed 18 h later. Naip1-6fl/fl 
mice showed induction of apoptosis in the colon, with in-
creased immunoreactivity for TUNEL and active caspase 3, 
whereas this was significantly reduced in Naip1-6/ colons 
(Fig. 7, A and B). This illustrates a failure to induce apoptosis 
upon AOM administration in the absence of NAIPs, which is 
contrary to their suggested IAP role. Consistent with this, 
Western blot analysis showed reduced activation of p53 (phos-
phorylation on S15 and stabilization of total p53) in Naip1-6/ 
compared with Naip1-6fl/fl mice (Fig. 7 C). Additionally, 
mRNA analysis revealed increased induction of Bid, the pro-
apoptotic p53 target, in Naip1-6fl/fl but not Naip1-6/ mice 
(Fig. 7 D). In contrast, Naip1-6/ mice showed up-regulation 
mRNA in colon homogenate of control and DSS-treated Naip1-6fl/fl mice at day 7 were measured by qPCR (normalized to GAPDH). (I) Western blot analy-
sis of IL-18, IL-1, and IL-22BP in colon homogenates from DSS-treated mice on day 7 (genotypes indicated, samples pooled for IL-1 and IL-22BP). 
(J) Male mice were injected i.p. with AOM (10 mg/kg) and the following day given DSS (2.5% wt/vol) in the drinking water for 7 d, followed by 2 d normal 
water. Relative expression levels of indicated mRNAs isolated from colons (normalized to 18S rRNA). n = 5 for Naip1-6fl/fl and n = 3 for Naip1-6/ mice (data 
are shown as mean ± SEM). Data are representative of two independent experiments. (K) Weight loss and colon lengths of Naip1-6fl/fl (n = 4), fl/ (n = 5), 
and / (n = 5) littermates undergoing acute DSS (2.5% wt/vol) induced colitis (7 d of DSS followed by normal water until day 11). Data representative of 
three independent experiments in B–F and of 2 independent experiments in G–K. Data shown were acquired with male mice. Two-way ANOVA was used 
for weight loss statistics and two-way Student’s t test for was used for other statistics. Data are shown as mean ± SEM. *, P < 0.05; **, P ≤ 0.01;  
***, P < 0.001; ****, P ≤ 0.0001.
 
Figure 5. Increased tumorigenesis in the absence of Naips is epithelium-intrinsic. Epithelial-specific (Naip1-6/IEC), or myeloid-specific  
(Naip1-6/LysM) Naip knockouts were exposed to the AOM/DSS CAC model as described in Fig. 3, except where indicated. Mice were sacrificed on day  
62. Littermates of both sexes were used (filled circles, males; open circles, females). (A) Naip1-6 mRNA in colon of Naip1-6fl/fl and Naip1-6/IEC mice (relative to 
18S RNA and expressed as percentage of transcript in Naip1-6fl/fl). (B) Naip1-6 mRNA in Ly6GCD11b+ (macrophage) and Ly6GCD11b (nonmyeloid) BM  
populations derived from Naip1-6fl/fl and Naip1-6/LysM mice (relative to 18S RNA and expressed as percentage of transcript in Naip1-6fl/fl). (C) Tumor 
burden and tumor size in Naip1-6fl/fl (n = 11) and Naip1-6/IEC (n = 6) littermates. Data were pooled from two independent experiments (in C, mice were 
treated with DSS [2.5%] for 5 d and normal water for 16 d for 3 cycles). (D) Tumor burden and tumor size in Naip1-6fl/fl (n = 5) and Naip1-6/LysM (n = 7) 
littermates, representative of two independent experiments. (E and F) Weight loss and colon length of mice treated as in C and D, respectively. Data are 
shown as mean ± SEM. *, P < 0.05; ****, P ≤ 0.0001.
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Immunoblots for IL-18, IL-1, and caspase-1 revealed no 
detectable activation of caspase-1 or downstream cleavage of 
IL-18 or IL-1 beyond basal levels in Naip1-6fl/fl or Naip1-6/ 
colons after AOM administration (Fig. 7 H). IL-22 protein 
levels also did not change (Fig. 7 H), which is in line with the 
mRNA levels (Fig. 7 F). There was a modest increase in 
IL-22BP in Naip1-6/ colons, the significance of which is 
unknown. Collectively, this data suggests that IL-22 signaling 
does not play a role in activation of STAT3 after AOM ex-
posure in Naip1-6/ mice. The mechanism of how STAT3 
is activated in Naip1-6/ colons after AOM administration 
remains to be determined. Altogether, these results demon-
strate that NAIPs suppress STAT3 activation after carcinogen 
exposure independent of the inflammasome axis and cyto-
kine production, and in an epithelium-intrinsic manner.
In summary, in the absence of NAIPs, we observed that 
colonic epithelial cells failed to induce apoptosis in response 
to AOM exposure. Instead, there was an induction of STAT3 
phosphorylation and signaling. This response to AOM was 
sufficient to drive tumorigenesis in an AOM-only model of 
CRC. In the colitis-associated cancer model, additional ele-
ments were at play. During acute colitis, similar to the altered 
response to AOM, we observed a change in gene expression 
indicative of a proliferative and protective epithelial response. 
However, by the stage of polyp induction, we could see greater 
induction of some inflammatory cytokines in Naip1-6/ 
compared with Naip1-6fl/fl mice. This is consistent with loss of 
barrier function within tumors as they develop (Grivennikov 
et al., 2012). Naip1-6/ mice also had increased pSTAT3 
and ki67 within tumors, which would account for the in-
crease in tumor size in this model.
DISCUSSION
In this study, we unveil a novel function for NAIPs in the 
suppression of colon tumorigenesis. Additionally, we also con-
firm the known role of NAIPs in the innate immune response 
of macrophages to Salmonella typhimurium and activation of 
inflammasome activity. In contrast to NAIP’s proposed role 
as inhibitors of apoptosis, NAIPs favored cell death at the ex-
pense of cell proliferation in the colonic epithelium under 
stress conditions. Under normal conditions, mice deficient 
for NAIPs do not have any abnormal phenotype. After insult 
with a chemical mutagen, Naip1-6/ mice failed to activate 
p53 compared with control Naip1-6fl/fl mice, which demon-
strated p53 stabilization, activation, and downstream induc-
tion of pro-apoptotic targets such as Bid (Fig. 7, A–D).
NAIPs also dampened the generation of pSTAT3 and its 
downstream effects on cell survival and proliferation (Bcl2 and 
Ccnd1 expression; Fig. 7, C and D). It remains to be deter-
mined how STAT3 is hyperphosphorylated in the absence of 
NAIPs. None of the cytokines or growth factors known to 
activate STAT3, that we checked, were altered at the mRNA 
level (Fig. 7 F). IL-22 and IL-22BP protein levels were also not 
affected in a way that would enable increased IL-22 signaling. 
The increase in STAT3 phosphorylation was also observed in 
Apcmin/+ intestinal tumor initiation (Musteanu et al., 2010). 
To determine if STAT3 was affected during the initiation 
phase of AOM exposure in Naip1-6/ mice, we analyzed 
phosphorylation of STAT3 in colon homogenates 18 h after 
AOM injection. Strikingly, Naip1-6/, but not Naip1-6fl/fl 
mice, had abundant phosphorylation of STAT3 (T705 and 
S727) after AOM injection (Fig. 7 C). Accordingly, expres-
sion of downstream targets of STAT3 (Bcl-2, Myc, and 
Ccnd1) was also increased in colons from Naip1-6/, but not 
Naip1-6fl/fl mice (Fig. 7, C and D). Increased STAT3 activation 
was also observed in Naip1-6/IEC, but not Naip1-6/LysM 
mice (Fig. 7 E), demonstrating an epithelial-intrinsic role for 
NAIPs in the early response to AOM. Activation of STAT3 
usually occurs via cytokine or growth factor signaling down-
stream of receptor tyrosine kinase activation (Levy and 
Darnell, 2002). Therefore, we checked expression of cytokines 
and growth factors IL-6, IL-11, IL-22, G-csf, and Gm-csf, 
as well as Socs3 (suppressor of cytokine signaling 3) by qRT-
PCR; however none of these factors changed after adminis-
tration of AOM, either between the genotypes or between 
AOM and control-treated mice (Fig. 7 F). This would indi-
cate that AOM does not affect expression of cytokines or 
growth factors. Overall, this data suggests that STAT3 activa-
tion occurs in an epithelial-intrinsic manner in the absence of 
NAIPs and could be an important impetus of tumor initia-
tion in the absence of NAIPs.
NAIPs regulate STAT3 phosphorylation  
independent of the inflammasome axis
Because NAIPs can act in concert with NLRC4 to induce 
inflammasome activity upon detection of intracellular patho-
gens, we tested whether NLRC4, Caspase-1, or ASC had 
any effect on STAT3 phosphorylation status. We injected 
Nlrc4/, Caspase-1/11/, Asc/, or WT mice with AOM 
(10 mg/kg) and checked colon homogenates 18 h later. No 
differences in STAT3 phosphorylation, or downstream target 
Bcl-2, were observed between any of the genotypes (Fig. 7 G). 
Figure 6. Increased tumorigenesis in Naip1-6/ mice in AOM-
induced CRC. Naip1-6fl/fl (n = 9) and Naip1-6/ (n = 7) mice were in-
jected with AOM (10 mg/kg) once per week for 6 wk and were analyzed at 
week 24. (A) Colonoscopy score assessed at week 24, (B) tumor burden 
(data are shown as mean ± SEM), and (C) tumor size assessed at 25 wk, 
expressed as percentage of tumors in the indicated size range, calculated 
on the entire cohort. In all panels, data are representative of two indepen-
dent experiments. Data from male mice are shown (similar results were 
obtained in female mice). *, P < 0.05; ****, P < 0.0001.
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of Naips remains to be elucidated. It is also unclear whether 
there is a causal link between reduced p53 activation and apop-
tosis in Naip1-6/ mice and STAT3 phosphorylation.
IEC-specific Naip-deficient mice, which would indicate an 
epithelial cell–intrinsic mechanism. Whether and how direct 
or indirect loss of inhibition of STAT3 occurs in the absence 
Figure 7. The early response to AOM is  
altered in Naip1-6/ mice. Naip1-6fl/fl and 
Naip1-6/ mice were injected with AOM (10 mg/kg) 
and colons were analyzed 18 h later. (A) Repre-
sentative sections of TUNEL staining on colon 
sections and quantification. 10 crypts in 5 inde-
pendent fields of view per mouse were counted. 
Data are expressed as number of TUNEL+ cells per 
crypt. (B) Quantification of active caspase-3+ cells 
in colon sections, performed as in A. (C) Western 
blot analysis of the indicated proteins in lysates 
prepared from whole-colon homogenates.  
(D) Relative expression of indicated mRNA from 
whole colon homogenates (normalized to 18S 
rRNA). Five mice per group, representative of 
three independent experiments (A–D and F). Data 
shown as mean ± SEM. (E) Levels of pSTAT3 in 
colon homogenates of Naip1-6/IEC, Naip1-6/LysM, 
or Naip1-6fl/fl littermates after 18 h AOM  
exposure. Representative of two independent 
experiments. (F) Relative expression of indicated 
STAT-3–inducing mRNA targets from Naip1-6fl/fl 
and Naip1-6/ whole colon samples as described 
for D. Data shown as mean ± SEM. (G) Nlrc4/, 
Caspase-1/11/, and Asc/ mice were injected 
with AOM (10 mg/kg) and colons were analyzed 
18 h later. Expression of pSTAT3 and Bcl-2 in 
colon homogenates was determined by Western 
blot (representative of two independent experi-
ments). (H) Western blot analysis of Caspase-1, 
IL-18, IL-1, IL-22, and IL-22BP in whole-colon 
homogenates from AOM and control-treated 
Naip1-6fl/fl and Naip1-6/ mice (representative 
of two independent experiments). *, P < 0.05;  
**, P ≤ 0.01; ****, P < 0.0001.
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tissue, in line with our observation that, in mice, Naips are 
down-regulated in colon tumor versus normal colon tissue 
(Fig. 3 G). This supports that down-regulation of NAIPs 
could play a role in human CRC. Additionally, data available 
on the Human Protein Atlas shows strong staining for NAIP 
in the human colon but weak staining in samples of colon 
adenocarcinoma. These results should prompt further interest 
into the role of NAIP in human CRC.
MATERIALS AND METHODS
General and specific deletion of Naip1-6 in mice
Mice were generated by Ozgene Pty. Ltd. as described in Fig. 1, on a C57BL/6 
background. To create full-body knockout of Naip1-6, the double “floxed” 
targeted mice were crossed with cre-deleter (JAX, B6.C-Tg(CMV-
cre)1Cgn/J) mice to remove the 250-kb Naip locus. The CMV-cre line 
within our facility was backcrossed 10 generations to C57BL/6 background, 
which should preclude contamination with non-B6 alleles. Resulting 
Naip1-6fl/fl or Naip1-6/ mice were maintained as concurrent WT (FL) or 
deficient (KO) lines (which were regularly renewed by intercrossing to avoid 
microbiota drift). Where indicated, mice were bred as heterozygote lines to 
use littermates. Tissue-specific deletion of Naip1-6 was achieved using 
Villin-Cre ( JAX, B6.SJL-Tg (Vil-cre)997Gum/J) and LysM-Cre mice ( JAX, 
B6.129P2-Lyz2tm1(cre)Ifo/J), which were also backcrossed in our facility at 
least 10 times on a C57BL/6 background. Genotyping of Naip1-6–deficient 
mice by PCR was performed on ear biopsy lysates using the following primers: 
5-TTGCTGTACTGACATCTGG-3 (fwd), 5-TCATACAATTCAG-
GATGGAA-3 (rev), 5-TGCTGACAGGACAGATATGA-3 (fwd), and 
5-TAGAATTAATTCGCCAGGC-3 (rev). Nlrc4/, Asc/ (Mariathasan 
et al., 2004), and Caspase-1/11/ (Kuida et al., 1995) mice were described 
previously. Nonlittermate WT control mice for these lines were bred and 
maintained in the same facility. Mice were handled according to Swiss 
Federal Veterinary Office guidelines, and protocols were approved by the 
Office Vétérinaire Cantonal du Canton de Vaud. Mice are now main-
tained at RIKEN.
Models of CRC and colitis
Colitis and colitis-associated cancer was induced as previously described 
(Wirtz et al., 2007). In brief:
AOM/DSS CAC. Mice were injected i.p. on day 1 with AOM (10 mg/kg; 
Sigma-Aldrich). On day 0 dextran sodium sulfate (DSS; MW 36,000–50,000; 
MP Biochemicals) was given in the drinking water (2.5% wt/vol) for 7 d 
(unless otherwise specified), followed by 14 d normal water; DSS treatment 
was repeated twice. Mice were sacrificed and tissue was analyzed between 
days 52 and 62. Colons were excised and washed and tumors were counted 
using a dissecting microscope. Colons were either fixed in formalin and par-
affin-embedded for histological analysis or tumor and normal tissue was dis-
sected and frozen immediately for later analysis.
Colitis. Acute colitis was induced by administering 2.5% (wt/vol) DSS in 
the drinking water for 7 d. Mice were weighed every day and percent of 
body weight change for each mouse was calculated. Clinical scores are a 
combination of weight loss, rectal bleeding, and stool consistency (between 
0 and 4, with 0 being normal and 1–4 being diarrhea) as described previously 
(Cooper et al., 1993). Mice were sacrificed at day 7. Colons were removed, 
measured, weighed, washed, and fixed in 10% buffered formalin. A section 
of the colon was taken for MPO or RNA analyses.
AOM-induced CRC. AOM (Sigma-Aldrich) was injected i.p. (10 mg/kg) 
once per week for 6 wk. After 24 wk, mice were assessed by colonoscopy 
for development of tumors. For analysis of the early response to AOM, mice 
were sacrificed 18 h after AOM injection.
We determined that NAIP’s effect on the early activation 
of STAT3 was independent of the NLRC4 inflammasome, 
because Nlcr4/, Asc/, and Casp-1/11/ mice did not 
exhibit a similar dysregulation of STAT3 (Fig. 7 G). How-
ever it is uncertain as to whether the phenotype of Naip1-6/ 
mice in the AOM/DSS CAC model is independent of 
NLRC4. Caspase-1/ and Nlrc4/ mice have also been re-
ported to have increased tumorigenesis in the AOM/DSS 
CAC model (Hu et al., 2010); however, another study re-
ported no role for NLRC4 (Allen et al., 2010). The study by 
Hu et al. (2010), demonstrated that, similar to Naip1-6/ 
mice, Nlrc4/ and Caspase-1/ mice display an epithelial-
intrinsic increase in tumorigenesis that was not dependent on 
IL-1 or IL-18. Their results differ to the Naip1-6/ pheno-
type in that Nlrc4/ and Caspase-1/ mice have equivalent 
levels of DSS-induced colitis compared with WT counter-
parts (which we saw similarly for Nlrc4/ in our laboratory; 
unpublished data), whereas Naip1-6/ mice have decreased 
susceptibility. Therefore, it appears that there are some dif-
ferences between Naip1-6/ mice and Nlrc4/ mice. It is 
likely that some epithelial-intrinsic functions of NAIPs are 
mediated via NLRC4, such as NAIP/NLRC4 inflamma-
some-mediated extrusion of S.Tm-infected enterocytes (Sellin 
et al., 2014). However, it is also apparent that there are some 
NLRC4-independent functions of NAIPs. This is not surpris-
ing because NAIPs contain three BIR domains, which can 
mediate a variety of functions.
We propose that increased tumorigenesis observed in 
Naip-deficient mice challenged with a chemical carcinogen 
results from decreased cell death of damaged/mutated cells 
during the initiation stage with AOM and from a growth 
advantage throughout tumor development. Further, similar 
mechanisms may be at play upon stress imposed by DSS, 
where damage is being compensated by a robust proliferation 
and survival response in the absence of NAIPs. Naip defi-
ciency and/or constitutive STAT3 activation may confer 
tumor cells with survival and proliferation signals usually pro-
vided by an inflammatory context and provide a rational ex-
planation for the observed dissociation between tumorigenesis 
and inflammation in these mice. Finally, although inflamma-
tion does promote tumor growth—hence, development of 
colorectal tumors within a relatively short period of time in 
the AOM/DSS model—the level of inflammation does not 
necessarily directly correlate with tumor burden, as shown in 
Naip1-6/ mice. Instead, it would appear that different types 
of tissue responses to stressors could have the capacity to drive 
tumorigenesis. This has implications for the identification of 
populations at risk of developing CRC.
As Naip1-6/ mice experienced deletion of a large ge-
nomic fragment, a possible contribution of intergenic elements 
to the phenotype should be kept in mind. Although currently 
available genome browsers did not detect micro RNAs or 
other elements predicted to be important in this region.
A previous study (Endo et al., 2004) found that NAIP 
mRNA expression was decreased in well and moderately dif-
ferentiated colon adenocarcinoma, compared with adjacent 
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BM-derived macrophage culture
BM was flushed from the tibia and femur, red blood cells were lysed, and cells 
were cultured in BMDM medium (DMEM, 10% FCS, 20% supernatant from 
L929 cell-conditioned medium, 1% Penicillin-Streptomycin (10 000 U/ml; 
Invitrogen) in 10 cm culture Petri dishes for 6–7 d. Adherent cells were 
lifted from the Petri dish using Accutase (Invitrogen).
In vitro TLR and inflammasome stimulation
Naip1-6fl/fl or Naip1-6/ BMDM (2.5 × 105 cells per stimulation) were pre-
stimulated with LPS (20 ng/ml), and then infected with S.Tm (SB300 WT) 
at the indicated MOI for 20 min (Salmonella strains were supplied by W.-D. 
Hardt, ETH, Zurich, Switzerland). Cells were then washed to remove ex-
tracellular bacteria and incubated for a further 2 h with medium containing 
gentamycin. Supernatants were then removed for ELISA and LDH analysis. 
For TLR and other inflammasome stimulation (shown by Western blot) cells 
were incubated for 6 h with the indicated stimuli.
ELISA and lactate dehydrogenase measurements
ELISA (eBioscience) and LDH assays (Cayman Chemical) were performed 
as per manufacturer’s instruction using 50 µl of cell culture supernatants.
Statistical analysis
Data were analyzed using GraphPad Prism Software. Two-tailed Student’s 
t test was used for comparison between two groups, and two-way ANOVA 
was used when two independent variables were being assessed. A P-value 
equal or less than P = 0.05 was considered statistically significant. Data shown 
are mean ± SEM, unless otherwise stated.
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Colonoscopy procedures
Colonoscopy was performed using a Coloview miniendoscopic system, con-
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Histology
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RNA isolation and qPCR
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Colon tissue analysis
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(Thermo Fisher Scientific). Myeloperoxidase was measured in colon ho-
mogenates as previously described (Vieira et al., 2005).
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FACS analysis
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